Ransom Advisory’s Biogen BIIB Stock Holding History

Ransom Advisory’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$15.8K	Hold	90	–	–	0.01%	317
2025 Q3	$12.6K	Hold	90	–	–	0.01%	242
2025 Q2	$11.3K	Sell	90 -50	-36%	-$6.23K	0.01%	270
2025 Q1	$19.2K	Hold	140	–	–	0.01%	248
2024 Q4	$21.4K	Sell	140 -150	-52%	-$25.3K	0.01%	290
2024 Q3	$56.2K	Hold	290	–	–	0.03%	206
2024 Q2	$67.2K	Buy	290 +50	+21%	+$10.9K	0.03%	181
2024 Q1	$51.8K	Buy	+240	New	+$56.2K	0.03%	187

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ransom Advisory's BIIB Position: Q4 2025 in Review

Ransom Advisory held its Biogen (BIIB) position steady in Q4 2025 at 90 shares worth $15.8K. The position accounts for 0.01% of the portfolio, ranked #317.

Ransom Advisory first reported a position in BIIB in Q1 2024 and has held it in 8 quarters since. The position peaked at $67.2K in Q2 2024. 998 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

Ransom Advisory held 90 shares of Biogen worth $15.8K as of Q4 2025.
Ransom Advisory left its Biogen share count unchanged in Q4 2025.
Biogen made up 0.01% of Ransom Advisory's portfolio in Q4 2025, its #317 holding.
Ransom Advisory first reported a position in Biogen in Q1 2024 and has held it in 8 quarters since.
Ransom Advisory's Biogen position peaked at $67.2K in Q2 2024.
998 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.